Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000899243-19-023128

Chief Commerical Officer bought 4,329 shares at $4.68 ($20,260)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
McMullin David Chief Commerical Officer 2019-09-05 Purchase +4,329 $4.68 $20,260 6,148 D
Open-market purchases · 4,329 sh · avg $4.68 · $20,260
Loading xslF345X03/doc4.xml…